Turn recording back on
Immunoprophylaxis of respiratory syncytial virus: global experience.
Simoes EA.
Respir Res. 2002;3 Suppl 1:S26-33. Review.
PMID: 12119055 [PubMed - indexed for MEDLINE]
Related Articles Free article in PMC
Respiratory syncytial virus prophylaxis--the story so far.
Simoes EA, Groothuis JR.
Respir Med. 2002 Apr;96 Suppl B:S15-24. Review.
PMID: 11996400 [PubMed - indexed for MEDLINE]
Related Articles
Incidence of respiratory syncytial virus-related hospitalizations in high-risk children: follow-up of a national cohort of infants treated with Palivizumab as RSV prophylaxis.
Lacaze-Masmonteil T, Rozé JC, Fauroux B; French Pediatricians' Group of Sunagis Patients' Name-Based Programs.
Pediatr Pulmonol. 2002 Sep;34(3):181-8.
PMID: 12203846 [PubMed - indexed for MEDLINE]
Palivizumab and the prevention of respiratory syncytial virus illness in pediatric patients with congenital heart disease.
Feltes TF, Sondheimer HM.
Expert Opin Biol Ther. 2007 Sep;7(9):1471-80. Review.
PMID: 17727335 [PubMed - indexed for MEDLINE]
Respiratory syncytial virus infections in children.
Staat MA.
Semin Respir Infect. 2002 Mar;17(1):15-20. Review.
PMID: 11891515 [PubMed - indexed for MEDLINE]
Prevention of respiratory syncytial virus infections in high-risk infants by monoclonal antibody (palivizumab).
Groothuis JR, Nishida H.
Pediatr Int. 2002 Jun;44(3):235-41. Review.
PMID: 11982888 [PubMed - indexed for MEDLINE]
Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.
Romero JR.
Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S46-54.
PMID: 12671452 [PubMed - indexed for MEDLINE]
Palivizumab for respiratory syncytial virus prophylaxis.
Sandritter T.
J Pediatr Health Care. 1999 Jul-Aug;13(4):191-5; quiz 196-7. Review.
PMID: 10690084 [PubMed - indexed for MEDLINE]
[Respiratory syncytial immunoprophylaxis with palivizumab]
De Halleux V, Lombet J, Rigo J.
Rev Med Liege. 2007 May-Jun;62(5-6):299-302. Review. French.
PMID: 17725198 [PubMed - indexed for MEDLINE]
Palivizumab in the prevention of respiratory syncytial virus disease.
Krilov LR.
Expert Opin Biol Ther. 2002 Oct;2(7):763-9. Review.
PMID: 12387675 [PubMed - indexed for MEDLINE]
Development and use of palivizumab (Synagis): a passive immunoprophylactic agent for RSV.
Pollack P, Groothuis JR.
J Infect Chemother. 2002 Sep;8(3):201-6. Review.
PMID: 12373481 [PubMed - indexed for MEDLINE]
Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection.
Sáez-Llorens X, Moreno MT, Ramilo O, Sánchez PJ, Top FH Jr, Connor EM; MEDI-493 Study Group.
Pediatr Infect Dis J. 2004 Aug;23(8):707-12.
PMID: 15295219 [PubMed - indexed for MEDLINE]
Palivizumab: an overview.
Russell AB.
Hosp Med. 1999 Dec;60(12):873-7. Review.
PMID: 10707171 [PubMed - indexed for MEDLINE]
Prophylaxis against respiratory syncytial virus in young children with cystic fibrosis.
Giebels K, Marcotte JE, Podoba J, Rousseau C, Denis MH, Fauvel V, Laberge S.
Pediatr Pulmonol. 2008 Feb;43(2):169-74.
PMID: 18085710 [PubMed - indexed for MEDLINE]
Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes.
Oh PI, Lanctĵt KL, Yoon A, Lee DS, Paes BA, Simmons BS, Parison D, Manzi P; Composs Investigators.
Pediatr Infect Dis J. 2002 Jun;21(6):512-8.
PMID: 12182374 [PubMed - indexed for MEDLINE]
Respiratory syncytial virus prevention: past and present strategies.
Greenough A, Thomas M.
Expert Opin Pharmacother. 2000 Sep;1(6):1195-201. Review.
PMID: 11249487 [PubMed - indexed for MEDLINE]
Respiratory syncytial virus infection: clinical features, management, and prophylaxis.
Greenough A.
Curr Opin Pulm Med. 2002 May;8(3):214-7. Review.
PMID: 11981311 [PubMed - indexed for MEDLINE]
Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants.
Pedraz C, Carbonell-Estrany X, Figueras-Aloy J, Quero J; IRIS Study Group.
Pediatr Infect Dis J. 2003 Sep;22(9):823-7.
PMID: 14506376 [PubMed - indexed for MEDLINE]
Palivizumab: a review of its use as prophylaxis for serious respiratory syncytial virus infection.
Fenton C, Scott LJ, Plosker GL.
Paediatr Drugs. 2004;6(3):177-97.
PMID: 15170364 [PubMed - indexed for MEDLINE]
Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease.
Feltes TF, Cabalka AK, Meissner HC, Piazza FM, Carlin DA, Top FH Jr, Connor EM, Sondheimer HM; Cardiac Synagis Study Group.
J Pediatr. 2003 Oct;143(4):532-40.
PMID: 14571236 [PubMed - indexed for MEDLINE]